Skip to content
← Absci

Vice President, Clinical Operations

Absci · United States - Remote

Bio & Science AIremoteexecutive$295k–$355k
Apply on the lab’s site ↗

At a glance

Highlights

  • Lead end-to-end sponsor operations for Phase 1/2 and global Phase 3 program.
  • Translate clinical strategy into global operational plan for registrational study.
  • Advance novel therapeutics built on generative AI drug creation platform.

What they offer

  • equity
  • bonus

Ideal candidate

Seasoned global clinical operations leader who thrives blending strategy with hands-on execution, driving urgency, accountability and quality to deliver complex late-stage programs.

Requirements

  • Substantial experience leading complex global late-stage and registrational programs
  • End-to-end Sponsor operational leadership across CROs, vendors, sites and functions
  • Comfortable combining strategic leadership with hands-on execution in lean biotech
  • Strong cross-functional leadership and ability to influence senior stakeholders
  • Excellent executive communication, judgment, problem-solving and decision-making skills

Lab profile

About Absci

Clinical-stage biotech using generative AI and synthetic biology to design novel therapeutics.

What they build

  • Integrated Drug Creation platform
  • AI-designed novel therapeutics

Known for

  • Generative AI models
  • Synthetic biology data engine
  • Antibody design

Key facts

  • Headquartered in Vancouver, WA
  • Offices in New York City, Switzerland, and Serbia
  • Clinical-stage biotechnology company
More about Absci →
Apply on the lab’s site ↗

Posted · Last seen